ANCA-associated vasculitis following influenza vaccination: Causal association or mere coincidence?

Journal of Clinical Rheumatology

Volumn 15, Issue 6, 2009, Pages 289-291

  Birck, Rainer ^a,d   Kaelsch, Isabelle ^a   Schnuelle, Peter ^a   Flores Suárez, Luis Felipe ^b   Nowack, Rainer ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c Center for Dialysis and Nephrology Lindau   (Germany)

^d V Medizinische Klinik   (Germany)

Author keywords

ANCA; Influenza vaccination; Relapse; Safety

Indexed keywords

CLARITHROMYCIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; INFLUENZA VACCINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ACUTE RESPIRATORY FAILURE; ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; AUTOIMMUNE DISEASE; BRONCHOPNEUMONIA; BRONCHOSCOPY; CAPILLARITIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNE COMPLEX NEPHRITIS; INFLUENZA; INFLUENZA VACCINATION; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; LABORATORY TEST; LUNG LAVAGE; LUNG NODULE; MAINTENANCE THERAPY; MALE; MEDICAL LITERATURE; MICROSCOPIC POLYANGIITIS; PNEUMONIA; PRIORITY JOURNAL; PULMONARY CAPILLARITIS; RECURRENT DISEASE; RISK; WEGENER GRANULOMATOSIS;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA VACCINES; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; RISK FACTORS;

EID: 70349136309     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181b55fe4     Document Type: Article

References (41)

1. Update: influenza activity-United States and worldwide, 2005-2006 season, and composition of the 2006-07 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2006;55:648-653.
2. Hak E, Nordin J, Wei F, et al. Influence of high risk medical conditions on the effectiveness of influenza vaccination among elderly members of three large managed care organizations. Clin Infect Dis. 2002;35:370-376.
3. Hak E, Buskens E, van Essen GA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med. 2005;165:274-280.
4. Centres for Disease Control and Prevention. Recommended adult immunisation schedulee-United States, October 2006-September 2007. Available at: http://www.cdc.gov/nip/recs/adult-schedule.htm.
5. STIKO. Hinweise zu Impfungen für Patienten mit Immundefizienz. Epidemiol Bull. 2005;353-364. Available from: http://www.rki.de.
6. Schattner A. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine. 2005;23:3876-3886.
7. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison? J Autoimmun. 2000;14:1-10.
8. Toplak N, Kveder T, Trampus-Bakija A, et al. Autoimmune response following annual influenza vaccination in 92 apparently healthy adults. Autoimmun Rev. 2008;8:134-138.
9. Marks JS, Halpin TJ. Guillain-Barré syndrome in recipients of A/New Jersey influenza vaccine. JAMA. 1980;243:2490-2494.
10. Jonville-Béra AP, Autret E, Galy-Eyraud C, et al. Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French regional pharmacovigilance centres and pasteur-mérieux sérums et vaccins. Pediatr Infect Dis J. 1996;15:44-48.
11. Wharton CF, Pietroni R. Polyarteritis after influenza vaccination. Br Med J. 1974;2:331-332.
12. Damjanov J, Amato JA. Progression of renal disease in Henoch-Schönlein purpura after influenzavaccination. JAMA. 1979;242:2555-2556.
13. Blumberg S, Bienfang D, Kantrowitz FG. A possible association between influenza vaccination and small-vessel vasculitis. Arch Intern Med. 1980;140: 847-848.
14. Gavaghan T, Webber CK. Severe systemic vasculitic syndrome post influenza vaccination. Aust N Z J Med. 1993;23:220.
15. Patel U, Bradley JR, Hamilton DV. Henoch-Schönlein purpura after influenza vaccination. Br Med J (Clin Res Ed). 1988;296:1800.
16. Houston TP. Small-vessel vasculitis following simultaneous influenza and pneumococcal vaccination. N Y State J Med. 1983;83:11-12.
17. Mader R, Narendran A, Lewtas J, et al. Systemic vasculitis following influenza vaccination-report of 3 cases and literature review. J Rheumatol. 1993;20:1429-1431.
18. Kelsall JT, Chalmers A, Sherlock CH, et al. Microscopic polyangiitis after influenza vaccination. J Rheumatol. 1997;24:1198-1202.
19. Perez C, Loza E, Tinture T. Giant cell arteritis after influenza vaccination. Arch Intern Med. 2000;160:2677.
20. Finsterer J, Artner C, Kladosek A, et al. Cavernous sinus syndrome due to vaccination-induced giant cell arteritis. Arch Intern Med. 2001;161:1008-1009.
21. Watanabe T, Onda H. Henoch-Schönlein purpura with antiphospholipid antibodies following an influenza vaccination. Pediatr Nephrol. 2001;16: 458-459.
22. Yanai-Berar N, Ben-Itzhak O, Gree J, et al. Influenza vaccination induced leukocytoclastic vasculitis and pauci-immune crescentic glomerulonephritis. Clin Nephrol. 2002;58:220-223.
23. Tavadia S, Drummond A, Evans CD, et al. Leucocytoclastic vasculitis and influenza vaccination. Clin Exp Dermatol. 2003;28:154-156.
24. Iyngkaran P, Limaye V, Hill C, et al. Rheumatoid vasculitis following influenza vaccination. Rheumatology (Oxford). 2003;42:907-909.
25. Famularo G, Nicotra GC, Minisola G, et al. Leukocytoclastic vasculitis after influenza vaccination. J Clin Rheumatol. 2006;12:48-50.
26. Uji M, Matsushita H, Iwata S. Microscopic polyangiitis after influenza vaccination. Intern Med. 2005;44:892-896.
27. Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol. 1997;8:314-322.
28. Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: what is the evidence? Lancet. 2003;15:1659-1666.
29. Abu-Shakra M, Press J, Buskila D, et al. Influenza vaccination of patients with systemic lupus erythematosus: safety and immunogenecity issues. Autoimmun Rev. 2007;6:543-546.
30. Elkayam O. Safety and efficacy of vaccination against influenza in patients with rheumatoid arthritis. Clin Dev Immunol. 2006;13:349-351.
31. Conti F, Rezai S, Valesini G. Vaccination and autoimmune rheumatic diseases. Autoimmun Rev. 2008;8:124-128.
32. Rutschmann O, McCrory D, Matchar D. Immunization and MS: a summary of published evidence and recommendations. Neurology. 2002;59:1837-1843.
33. Holvast A, Huckriede A, Wilschut J, et al. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis. 2006;65:913-918.
34. Chalmers A, Scheifele D, Patterson C, et al. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol. 1994;21:1203-1206.
35. Stassen PM, Sanders JS, Kallenberg CG, et al. Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitis. Nephrol Dial Transplant. 2008;23:654-658.
36. Holvast A, Stegeman CA, Benne CA, et al. Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination. Ann Rheum Dis. 2009;68:873-878.
37. Zycinska K, Romanowska M, Nowak I, et al. Antibody response to inactivated subunit influenza vaccine in patients with Wegener's granulomatosis. J Physiol Pharmacol. 2007;58 (suppl 5, pt 2):819-828.
38. Jennette JC, Xiao H, Falk RJ. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol. 2006;17:1235-1242.
39. Tsai MY, Hanson NQ, Straka RJ, et al. Effect of influenza vaccine on markers of inflammation and lipid profile. J Lab Clin Med. 2005;145:323-327.
40. Van der Beek M, Visser L, de Maat M. Yellow fever vaccination as a model to study the response to stimulation of the inflammation system. Vascul Pharmacol. 2002;39:117-121.
41. Verschuur M, van der Beek MT, Tak HS, et al. Interindividual variation in the response by fibrinogen, C-reactive protein and interleukin-6 to yellow fever vaccination. Blood Coagul Fibrinolysis. 2004;15:399-404.